The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic biomarkers in relation to PD-1 checkpoint blockade response.
 
Tanguy Y. Seiwert
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Innate Pharma; Jounce Therapeutics; Lilly; Merck; Merck Serono
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
 
Razvan Cristescu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Robin Mogg
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Mark Ayers
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrew Albright
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Xinwei Sher
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Xiaoqiao Liu
Employment - MSD
Stock and Other Ownership Interests - MSD
 
Michael Nebozhyn
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Chunsheng Zhang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jared Lunceford
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrew K. Joe
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrea L Webber
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Nageatte Ibrahim
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Elizabeth R. Plimack
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Genentech/Roche; Horizon Pharma; Inovio Pharmaceuticals; Lilly; Novartis; Pfizer
Research Funding - Acceleron Pharma (Inst); Agensys (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst); US Patent No: 15/226,474 files on 7/1/15 (Inst)
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Neon Therapeutics
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst)
 
Antoni Ribas
Stock and Other Ownership Interests - Advaxis; Arcus Ventures; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis; Pierre Fabre
 
Terrill McClanahan
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Andrey Loboda
Employment - Merck
Stock and Other Ownership Interests - Merck
 
David Ross Kaufman
Employment - Merck
Stock and Other Ownership Interests - Merck